跳至主要内容
临床试验/IRCT20171230038142N16
IRCT20171230038142N16招募中2 期

The evaluation effects of the Livercare tablet (combination of Milk Thistle, Dandelion, Barberry, Tumeric (Curcumin) and Artichoke) in the prevention of anti-tuberculosis drugs-induced hepatotoxicity

Esfahan University of Medical Sciences0 个研究点目标入组 44 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 65 years(—)
性别
All

入选标准

  • Age range 20 to 65
  • Active pulmonary or extrapulmonary tuberculosis
  • No first-line anti-tuberculosis drugs (isoniazid, rifampin, pyrazinamide) in all patients in the past 8 weeks and starting on treatment
  • No known hepatotoxic drugs (sodium valproate, methotrexate and sulfonamides)
  • No continuous use of acetaminophen
  • No systemic glucocorticoids, supplements containing thistle, dandelion, barberry, turmeric or artichoke in the past 4 weeks

排除标准

  • Patient dissatisfaction
  • alcohol consumption
  • liver disease
  • Discontinue medication for any reason other than liver toxicity
  • Patient Withdrawal from Study Continuation
  • Not taking the study tablet for at least 3 consecutive days

研究者

相似试验